Prelude Therapeutics 2023 SVB Global Biopharma Conference

Prelude Therapeutics presented its precision medicine oncology pipeline at the SVB Global Biopharma Conference in February 2023. The company highlighted its diverse clinical-stage small molecule candidates targeting various cancers, including PRT543, PRT811, PRT1419, and others in development. Prelude emphasized its commercial opportunities, well-capitalized position, and exceptional R&D capabilities.